Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Clinical trial NCT07488572 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07488572
Sponsor: Sun Yat-sen University
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)Metastatic Clear Cell Renal Cell Carcinoma

Start date: 2025-11-01
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.